Veterinary Medicines Information website

NOBILIS RT + IBmulti + ND + EDS

Authorised
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated

Product identification

Medicine name:
NOBILIS RT + IBmulti + ND + EDS
Active substance:
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
Target species:
  • Chicken (for reproduction)
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
    6.50
    log2 haemagglutination inhibiting unit(s)
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    5.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    9.50
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA18
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120265
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 2/04/2024